CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $291,000 | +282.9% | 117,770 | +458.6% | 0.01% | +300.0% |
| Q1 2017 | $76,000 | -84.9% | 21,083 | -85.1% | 0.00% | -83.3% |
| Q4 2016 | $502,000 | +110.9% | 141,722 | +161.0% | 0.01% | +140.0% |
| Q2 2016 | $238,000 | +135.6% | 54,297 | +103.5% | 0.01% | +66.7% |
| Q1 2016 | $101,000 | -78.6% | 26,684 | -11.3% | 0.00% | -62.5% |
| Q4 2015 | $471,000 | -6.5% | 30,067 | -37.1% | 0.01% | 0.0% |
| Q3 2015 | $504,000 | -3.4% | 47,825 | +131.2% | 0.01% | -11.1% |
| Q2 2015 | $522,000 | +59.1% | 20,684 | +75.8% | 0.01% | +28.6% |
| Q1 2015 | $328,000 | -30.9% | 11,763 | -54.8% | 0.01% | -12.5% |
| Q4 2014 | $475,000 | +15.6% | 26,033 | -17.9% | 0.01% | 0.0% |
| Q3 2014 | $411,000 | +109.7% | 31,701 | +163.0% | 0.01% | +166.7% |
| Q2 2014 | $196,000 | -50.3% | 12,053 | -45.9% | 0.00% | -40.0% |
| Q1 2014 | $394,000 | -74.1% | 22,273 | -48.1% | 0.01% | -73.7% |
| Q3 2013 | $1,520,000 | – | 42,901 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,025,000 | $24,815,000 | 31.36% |
| TSP Capital Management Group, LLC | 836,342 | $20,248,000 | 8.80% |
| Iguana Healthcare Management, LLC | 200,000 | $4,842,000 | 2.76% |
| First Light Asset Management, LLC | 116,096 | $2,811,000 | 2.38% |
| SECTORAL ASSET MANAGEMENT INC | 2,227,688 | $53,932,000 | 2.33% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 550,735 | $13,334,000 | 2.05% |
| Eventide Asset Management | 257,000 | $6,222,000 | 1.92% |
| Redmile Group, LLC | 397,951 | $9,634,000 | 1.19% |
| ARDSLEY ADVISORY PARTNERS LP | 357,000 | $8,643,000 | 1.15% |
| Rhenman & Partners Asset Management AB | 90,000 | $2,179,000 | 0.85% |